Information Collection: Destinations of Released Patients Following Treatment with Iodine-131 and Estimation of Doses to Members of the Public at Locations other than Conventional Residences Receiving Such Patients, 28715-28716 [2015-12017]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices
Material Safety and Safeguards as a
basis for decisions about the
commitment of NRC staff resources to
the consultation and participation
efforts. The NRC anticipates conducting
a public rulemaking to revise portions of
10 CFR part 60 in the near future (i.e.,
within the next 5 years). If, as part of
this rulemaking, revisions are made
affecting the information collection
requirements, the NRC will follow OMB
requirements for obtaining approval for
any revised information collection
requirements. [Note: All of the
information collection requirements
pertaining to Yucca Mountain were
included in 10 CFR Part 63, and were
approved by OMB under control
number 3150–0199. The Yucca
Mountain site is regulated under 10 CFR
part 63 (66 FR 55792, November 2,
2001).]
III. Specific Requests for Comments
The NRC is seeking comments that
address the following questions:
1. Is the proposed collection of
information necessary for the NRC to
properly perform its functions? Does the
information have practical utility?
2. Is the estimate of the burden of the
information collection accurate?
3. Is there a way to enhance the
quality, utility, and clarity of the
information to be collected?
4. How can the burden of the
information collection on respondents
be minimized, including the use of
automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 13th day
of May 2015.
For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information
Services.
[FR Doc. 2015–12018 Filed 5–18–15; 8:45 am]
comment on this proposed collection of
information of Office of Management
and Budget (OMB) approval for a
proposed collection of information. The
information collection is entitled,
‘‘Destinations of Released Patients
Following Treatment with Iodine-131
and Estimation of Doses to Members of
the Public at Locations other than
Conventional Residences Receiving
Such Patients.’’
DATES: Submit comments by July 20,
2015. Comments received after this date
will be considered if it is practical to do
so, but the Commission is able to ensure
consideration only for comments
received on or before this date.
ADDRESSES: You may submit comments
by any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2015–0102. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• Mail comments to: Tremaine
Donnell, Office of Information Services,
Mail Stop: T–5 F53, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
Tremaine Donnell, Office of Information
Services, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001; telephone: 301–415–6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
SUPPLEMENTARY INFORMATION:
BILLING CODE 7590–01–P
I. Obtaining Information and
Submitting Comments
NUCLEAR REGULATORY
COMMISSION
A. Obtaining Information
[NRC–2015–0102]
tkelley on DSK3SPTVN1PROD with NOTICES
Information Collection: Destinations of
Released Patients Following Treatment
with Iodine-131 and Estimation of
Doses to Members of the Public at
Locations other than Conventional
Residences Receiving Such Patients
Nuclear Regulatory
Commission.
ACTION: Proposed information
collection: Request for comment.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) invites public
SUMMARY:
VerDate Sep<11>2014
16:53 May 18, 2015
Jkt 235001
Please refer to Docket ID NRC–2015–
0102 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2015–0102. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing Docket ID
NRC–2015–0102 on this Web site.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly-
PO 00000
Frm 00137
Fmt 4703
Sfmt 4703
28715
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing ADAMS
Accession No.: ML15086A164. The
supporting statement available in
ADAMS under Accession No.
ML15086A166.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting NRC’s Clearance
Officer, Tremaine Donnell, Office of
Information Services, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
6258; email: INFOCOLLECTS.Resource@
NRC.GOV.
B. Submitting Comments
Please include Docket ID NRC–2015–
0102 in the subject line of your
comment submission, in order to ensure
that the NRC is able to make your
comment submission available to the
public in this docket.
The NRC cautions you not to include
identifying or contact information in
comment submissions that you do not
want to be publicly disclosed in your
comment submission. The NRC will
post all comment submissions at
https://www.regulations.gov as well as
enter the comment submissions into
ADAMS, and the NRC does not
routinely edit comment submissions to
remove identifying or contact
information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment into ADAMS.
E:\FR\FM\19MYN1.SGM
19MYN1
28716
Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
II. Background
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting
public comment on its intention to
request the OMB’s approval for the
information collection summarized
below.
1. The title of the information
collection: Destinations of Released
Patients Following Treatment with
Iodine-131 and Estimation of Doses to
Members of the Public at Locations
other than Conventional Residences
Receiving Such Patients.
2. OMB approval number: An OMB
control number has not yet been
assigned to this proposed information
collection.
3. Type of submission: New.
4. The form number, if applicable:
NA.
5. How often the collection is required
or requested: One-time.
6. Who will be required or asked to
respond: Institutions that treat thyroid
cancer patients with I–131 and the
thyroid cancer patients who have been
treated.
7. The estimated number of annual
responses: 5,175 (175 for treating
institutions and 5000 for individuals).
8. The estimated number of annual
respondents: 5,175.
9. The estimated number of hours
needed annually to comply with the
information collection requirement or
request: 1,675 (175 hours for treating
institution and 1500 hours for
individuals).
10. Abstract: Although most patients
return to their home after receiving
diagnostic or therapeutic of Iodine-131,
some patients released by the licensee
may stay at another location (such as a
hotel) for a few days. However, the
extent of this practice is unclear. The
same uncertainty exists regarding
patients returning to nursing homes and
other institutional settings. Therefore,
one of the main objectives of this study
is to obtain reliable statistical data that
provides good estimates of the
prevalence of these practices. The
second objective is to determine, by
measurements, the external and internal
doses received by members of the
general public at hotels, nursing homes,
or other institutional settings that
receive treated patients immediately
after their release.
III. Specific Requests for Comments
The NRC is seeking comments that
address the following questions:
1. Is the proposed collection of
information necessary for the NRC to
properly perform its functions? Does the
information have practical utility?
VerDate Sep<11>2014
16:53 May 18, 2015
Jkt 235001
2. Is the estimate of the burden of the
information collection accurate?
3. Is there a way to enhance the
quality, utility, and clarity of the
information to be collected?
4. How can the burden of the
information collection on respondents
be minimized, including the use of
automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 13th day
of May 2015.
For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information
Services.
[FR Doc. 2015–12017 Filed 5–18–15; 8:45 am]
BILLING CODE 7590–01–P
OFFICE OF PERSONNEL
MANAGEMENT
President’s Commission on White
House Fellowships Advisory
Committee: Closed Meeting
President’s Commission on
White House Fellowships, U.S. Office of
Personnel Management.
ACTION: Notice of meeting.
AGENCY:
The President’s Commission
on White House Fellowships (PCWHF)
was established by an Executive Order
in 1964. The PCWHF is an advisory
committee composed of Special
Government Employees appointed by
the President. The Advisory Committee
meet in June to interview potential
candidates for recommendation to
become a White House Fellow.
The meeting is closed.
Name of Committee: President’s
Commission on White House
Fellowships Selection Weekend.
Date: June 11–14, 2015.
Time: 7:00 a.m.–9:30 p.m.
Place: St. Regis Hotel, 16th & K Street,
Washington, DC 20006.
Agenda: The Commission will
Interview 30 National Finalists for
selection of new class of White House
Fellows.
Location: St. Regis Hotel, 16th and K
Street NW., Washington, DC 20006.
FOR FURTHER INFORMATION CONTACT:
Jennifer Y. Kaplan, 712 Jackson Place
NW., Washington, DC 20503, Phone:
202–395–4522.
SUMMARY:
President’s Commission on White House
Fellowships.
Jennifer Y. Kaplan,
Director.
[FR Doc. 2015–12085 Filed 5–18–15; 8:45 am]
BILLING CODE 6325–44–P
PO 00000
Frm 00138
Fmt 4703
Sfmt 4703
POSTAL REGULATORY COMMISSION
[Docket No. CP2014–78; Order No. 2482]
New Postal Product
Postal Regulatory Commission.
Notice.
AGENCY:
ACTION:
The Commission is noticing a
recent Postal Service filing concerning a
modification to a Global Expedited
Package Services 3 negotiated service
agreement. This notice informs the
public of the filing, invites public
comment, and takes other
administrative steps.
DATES: Comments are due: May 20,
2015.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
telephone for advice on filing
alternatives.
FOR FURTHER INFORMATION CONTACT:
David A. Trissell, General Counsel, at
202–789–6820.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Table of Contents
I. Introduction
II. Notice of Filings
III. Ordering Paragraphs
I. Introduction
On May 12, 2015, the Postal Service
filed notice that it has agreed to a
Modification to the existing Global
Expedited Package Services 3 negotiated
service agreement approved in this
docket.1 In support of its Notice, the
Postal Service includes a redacted copy
of the Modification and a certification of
compliance with 39 U.S.C. 3633(a), as
required by 39 CFR 3015.5. Notice,
Attachment 1 and 2.
The Postal Service also filed the
unredacted Modification and supporting
financial information under seal. Notice
at 2. The Postal Service seeks to
incorporate by reference the Application
for Non-Public Treatment originally
filed in this docket for the protection of
information that it has filed under seal.
Id.
The Modification updates the
customer’s mailing and contact
information, revises the choice of
payment method, and replaces Annex 1,
which contains new rates. Id. at 1; Id.
Attachment 1. The rates in the
1 Notice of the United States Postal Service of
Filing Modification to Global Expedited Package
Services 3 Negotiated Service Agreement, May 12,
2015 (Notice).
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 80, Number 96 (Tuesday, May 19, 2015)]
[Notices]
[Pages 28715-28716]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12017]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2015-0102]
Information Collection: Destinations of Released Patients
Following Treatment with Iodine-131 and Estimation of Doses to Members
of the Public at Locations other than Conventional Residences Receiving
Such Patients
AGENCY: Nuclear Regulatory Commission.
ACTION: Proposed information collection: Request for comment.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public
comment on this proposed collection of information of Office of
Management and Budget (OMB) approval for a proposed collection of
information. The information collection is entitled, ``Destinations of
Released Patients Following Treatment with Iodine-131 and Estimation of
Doses to Members of the Public at Locations other than Conventional
Residences Receiving Such Patients.''
DATES: Submit comments by July 20, 2015. Comments received after this
date will be considered if it is practical to do so, but the Commission
is able to ensure consideration only for comments received on or before
this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2015-0102. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
Mail comments to: Tremaine Donnell, Office of Information
Services, Mail Stop: T-5 F53, U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of
Information Services, U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001; telephone: 301-415-6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2015-0102 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2015-0102. A copy of
the collection of information and related instructions may be obtained
without charge by accessing Docket ID NRC-2015-0102 on this Web site.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. A
copy of the collection of information and related instructions may be
obtained without charge by accessing ADAMS Accession No.: ML15086A164.
The supporting statement available in ADAMS under Accession No.
ML15086A166.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
NRC's Clearance Officer: A copy of the collection of
information and related instructions may be obtained without charge by
contacting NRC's Clearance Officer, Tremaine Donnell, Office of
Information Services, U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001; telephone: 301-415-6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
B. Submitting Comments
Please include Docket ID NRC-2015-0102 in the subject line of your
comment submission, in order to ensure that the NRC is able to make
your comment submission available to the public in this docket.
The NRC cautions you not to include identifying or contact
information in comment submissions that you do not want to be publicly
disclosed in your comment submission. The NRC will post all comment
submissions at https://www.regulations.gov as well as enter the comment
submissions into ADAMS, and the NRC does not routinely edit comment
submissions to remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
[[Page 28716]]
II. Background
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting public comment on its intention to
request the OMB's approval for the information collection summarized
below.
1. The title of the information collection: Destinations of
Released Patients Following Treatment with Iodine-131 and Estimation of
Doses to Members of the Public at Locations other than Conventional
Residences Receiving Such Patients.
2. OMB approval number: An OMB control number has not yet been
assigned to this proposed information collection.
3. Type of submission: New.
4. The form number, if applicable: NA.
5. How often the collection is required or requested: One-time.
6. Who will be required or asked to respond: Institutions that
treat thyroid cancer patients with I-131 and the thyroid cancer
patients who have been treated.
7. The estimated number of annual responses: 5,175 (175 for
treating institutions and 5000 for individuals).
8. The estimated number of annual respondents: 5,175.
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 1,675 (175 hours for
treating institution and 1500 hours for individuals).
10. Abstract: Although most patients return to their home after
receiving diagnostic or therapeutic of Iodine-131, some patients
released by the licensee may stay at another location (such as a hotel)
for a few days. However, the extent of this practice is unclear. The
same uncertainty exists regarding patients returning to nursing homes
and other institutional settings. Therefore, one of the main objectives
of this study is to obtain reliable statistical data that provides good
estimates of the prevalence of these practices. The second objective is
to determine, by measurements, the external and internal doses received
by members of the general public at hotels, nursing homes, or other
institutional settings that receive treated patients immediately after
their release.
III. Specific Requests for Comments
The NRC is seeking comments that address the following questions:
1. Is the proposed collection of information necessary for the NRC
to properly perform its functions? Does the information have practical
utility?
2. Is the estimate of the burden of the information collection
accurate?
3. Is there a way to enhance the quality, utility, and clarity of
the information to be collected?
4. How can the burden of the information collection on respondents
be minimized, including the use of automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 13th day of May 2015.
For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-12017 Filed 5-18-15; 8:45 am]
BILLING CODE 7590-01-P
